American Society of Gene and Cell Therapy 2026 (ASGCT)

Back

Targeting Tauopathies: Robust and Widespread MAPT Silencing in CNS of Mice and NHP with TfR1-mediated Oligonucleotide Delivery (presentation)

View

©2026 Dyne Therapeutics, Inc. All rights reserved MED-00978. Date of preparation: July 2026.